Federal Register / Vol. 86, No. 133 / Thursday, July 15, 2021 / Notices 37325 

Respiratory Syndrome Coronavirus 2 

(SARS–CoV–2), the causal agent of 

COVID–19. The use is effective January 

19, 2021 to August 24, 2021. 

California 

Department of Pesticide Regulation 

Specific exemption: EPA authorized 

the use of kasugamycin on a maximum 

of 100,000 acres of almond trees to 

control bacterial blast (Pseudomonas 

syringae pv. syringae). A time-limited 

tolerance in connection with a past 

action has been established in 40 CFR 

180.614(b). Effective February 11, 2021 

to April 15, 2021. 

Florida 

Department of Agriculture and 

Consumer Services 

Specific exemptions: EPA authorized 

the use of streptomycin on up to 

330,254 acres of citrus to manage citrus 

greening disease (also known as 

Huanglongbing). Time-limited 

tolerances in connection with past 

actions for this use have been 

established in 40 CFR 180.245(b). 

Effective December 31, 2020 to 

December 31, 2021. 

EPA authorized the use of the 

insecticide clothianidin on a maximum 

of 125,376 acres of immature (3 to 5 

years old) citrus trees to control the 

Asian citrus psyllid, the vector of citrus 

greening disease (also known as 

Huanglongbing) to manage disease 

transmission. A time-limited tolerance 

in connection with this action has been 

established in 40 CFR 180.586(b); 

Effective January 1, 2021 to October 31, 

2021. 

Georgia 

Department of Agriculture 

Public health exemption: EPA 

authorized the use of triethylene glycol 

as an indoor air treatment at various 

sites in Georgia when adherence to 

current public health guidelines is 

impractical, difficult to maintain, or is 

not expected to provide a sufficient 

level of protection, to control the Severe 

Acute Respiratory Syndrome 

Coronavirus 2 (SARS–CoV–2), the 

causal agent of COVID–19. The use is 

effective January 14, 2021 to January 14, 

2022. 

Louisiana 

Department of Agriculture and Forestry 

Specific exemption: EPA authorized 

the use of triclopyr on a maximum of 

450,000 acres of sugarcane to control 

divine nightshade. A time-limited 

tolerance in connection with this action 

has been established in 40 CFR 

180.417(b); Effective October 2, 2020 to 

May 31, 2021. 

Massachusetts 

Department of Agriculture and 

Resources 

Specific exemption: EPA authorized 

the use of pronamide on a maximum of 

5,000 acres of cranberries to control 

dodder. A time-limited tolerance in 

connection with this action has been 

established in 40 CFR 180.679(b). 

Effective April 15, 2021 to June 30, 

2021. 

Oklahoma 

Department of Agriculture 

Public health exemption: EPA 

authorized the use of 1- 

octadecanaminium, N,N-dimethyl-N-[3- 

(trihydroxysilyl)propyl] chloride on 

non-porous, non-food-contact surfaces 

in American Airlines aircraft and airport 

facilities to control the Severe Acute 

Respiratory Syndrome Coronavirus 2 

(SARS–CoV–2), the causal agent of 

COVID–19. The use is effective January 

19, 2021 to August 24, 2021. 

Tennessee 

Department of Agriculture 

Public health exemption: EPA 

authorized the use of triethylene glycol 

as an indoor air treatment at various 

sites in Tennessee when adherence to 

current public health guidelines is 

impractical, difficult to maintain, or is 

not expected to provide a sufficient 

level of protection, to control the Severe 

Acute Respiratory Syndrome 

Coronavirus 2 (SARS–CoV–2), the 

causal agent of COVID–19. The use is 

effective January 14, 2021 to January 14, 

2022. 

B. Federal Departments and Agencies 

Agriculture Department 

Animal and Plant Health Inspector 

Service 

Quarantine Exemption: EPA 

authorized the use of acetic acid on 

nonporous surfaces to decontaminate 

from foot and mouth disease virus; 

Effective April 19, 2021 to April 19, 

2024. 

National Aeronautics and Space 

Administration 

Specific exemption: EPA authorized 

use of ortho-phthalaldehyde, 

immobilized to a porous resin, to treat 

the International Space Station (ISS) 

internal active thermal control system 

(IATCS) coolant for control of aerobic 

and microaerophilic water bacteria and 

unidentified gram-negative rods. 

Effective October 9, 2020 to October 9, 

2021. This request was granted because 

without this use, the ISS would have no 

means of controlling microorganisms in 

the IATCS because there are no 

registered alternatives available which 

meet the required criteria. Since this 

request proposed a use of a new 

(unregistered) chemical, in accordance 

with the requirements at 40 CFR 166.24, 

a notice of receipt published in the 

Federal Register on September 25, 2020 

(85 FR 60458) (FRL–10014–21) with the 

public comment period closing on 

October 13, 2020. 

Authority: 7 U.S.C. 136 et seq. 

Dated: July 9, 2021. 

Marietta Echeverria, 

Acting Director, Registration Division, Office 

of Pesticide Programs. 

[FR Doc. 2021–15043 Filed 7–14–21; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPPT–2021–0146; FRL–8682–01– 

OCSPP] 

Certain New Chemicals or Significant 

New Uses; Statements of Findings for 

May 2021 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: The Toxic Substances Control 

Act (TSCA) requires EPA to publish in 

the Federal Register a statement of its 

findings after its review of certain TSCA 

notices when EPA makes a finding that 

a new chemical substance or significant 

new use is not likely to present an 

unreasonable risk of injury to health or 

the environment. Such statements apply 

to premanufacture notices (PMNs), 

microbial commercial activity notices 

(MCANs), and significant new use 

notices (SNUNs) submitted to EPA 

under TSCA. This document presents 

statements of findings made by EPA on 

such submissions during the period 

from May 1, 2021 to May 31, 2021. 

FOR FURTHER INFORMATION CONTACT: 

For technical information contact: 

Rebecca Edelstein, New Chemical 

Division (7405M), Office of Pollution 

Prevention and Toxics, Environmental 

Protection Agency, 1200 Pennsylvania 

Ave. NW, Washington, DC 20460–0001; 

telephone number: 202–564–1667 email 

address: Edelstein.rebecca@epa.gov. 

For general information contact: The 

TSCA-Hotline, ABVI-Goodwill, 422 

South Clinton Ave., Rochester, NY 

14620; telephone number: (202) 554– 

1404; email address: TSCA-Hotline@

epa.gov. 


khammond on DSKJM1Z7X2PROD with NOTICES
37326 Federal Register / Vol. 86, No. 133 / Thursday, July 15, 2021 / Notices 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

This action is directed to the public 

in general. As such, the Agency has not 

attempted to describe the specific 

entities that this action may apply to. 

Although others may be affected, this 

action applies directly to the submitters 

of the PMNs addressed in this action. 

B. How can I get copies of this document 

and other related information? 

The docket for this action, identified 

by docket identification (ID) number 

EPA–HQ–OPPT–2021–0146, is available 

online at http://www.regulations.gov or 

in-person at the Office of Pollution 

Prevention and Toxics Docket (OPPT 

Docket), Environmental Protection 

Agency Docket Center (EPA/DC), West 

William Jefferson Clinton Bldg., Rm. 

3334, 1301 Constitution Ave. NW, 

Washington, DC. The Public Reading 

Room is open from 8:30 a.m. to 4:30 

p.m., Monday through Friday, excluding 

legal holidays. The telephone number 

for the Public Reading Room is (202) 

566–1744, and the telephone number for 

the OPPT Docket is (202) 566–0280. 

Due to the public health concerns 

related to COVID–19, the EPA Docket 

Center (EPA/DC) and Reading Room is 

closed to visitors with limited 

exceptions. The staff continues to 

provide remote customer service via 

email, phone, and webform. For the 

latest status information on EPA/DC 

services and docket access, visit https:// 

www.epa.gov/dockets. 

II. What action is the Agency taking? 

This document lists the statements of 

findings made by EPA after review of 

notices submitted under TSCA section 

5(a) that certain new chemical 

substances or significant new uses are 

not likely to present an unreasonable 

risk of injury to health or the 

environment. This document presents 

statements of findings made by EPA 

during the period from May 1, 2021 to 

May 31, 2021. 

III. What is the Agency’s authority for 

taking this action? 

TSCA section 5(a)(3) requires EPA to 

review a TSCA section 5(a) notice and 

make one of the following specific 

findings: 

• The chemical substance or 

significant new use presents an 

unreasonable risk of injury to health or 

the environment; 

• The information available to EPA is 

insufficient to permit a reasoned 

evaluation of the health and 

environmental effects of the chemical 

substance or significant new use; 

• The information available to EPA is 

insufficient to permit a reasoned 

evaluation of the health and 

environmental effects and the chemical 

substance or significant new use may 

present an unreasonable risk of injury to 

health or the environment; 

• The chemical substance is or will 

be produced in substantial quantities, 

and such substance either enters or may 

reasonably be anticipated to enter the 

environment in substantial quantities or 

there is or may be significant or 

substantial human exposure to the 

substance; or 

• The chemical substance or 

significant new use is not likely to 

present an unreasonable risk of injury to 

health or the environment. 

Unreasonable risk findings must be 

made without consideration of costs or 

other non-risk factors, including an 

unreasonable risk to a potentially 

exposed or susceptible subpopulation 

identified as relevant under the 

conditions of use. The term ‘‘conditions 

of use’’ is defined in TSCA section 3 to 

mean ‘‘the circumstances, as determined 

by the Administrator, under which a 

chemical substance is intended, known, 

or reasonably foreseen to be 

manufactured, processed, distributed in 

commerce, used, or disposed of.’’ 

EPA is required under TSCA section 

5(g) to publish in the Federal Register 

a statement of its findings after its 

review of a TSCA section 5(a) notice 

when EPA makes a finding that a new 

chemical substance or significant new 

use is not likely to present an 

unreasonable risk of injury to health or 

the environment. Such statements apply 

to PMNs, MCANs, and SNUNs 

submitted to EPA under TSCA section 

5. 

Anyone who plans to manufacture 

(which includes import) a new chemical 

substance for a non-exempt commercial 

purpose and any manufacturer or 

processor wishing to engage in a use of 

a chemical substance designated by EPA 

as a significant new use must submit a 

notice to EPA at least 90 days before 

commencing manufacture of the new 

chemical substance or before engaging 

in the significant new use. 

The submitter of a notice to EPA for 

which EPA has made a finding of ‘‘not 

likely to present an unreasonable risk of 

injury to health or the environment’’ 

may commence manufacture of the 

chemical substance or manufacture or 

processing for the significant new use 

notwithstanding any remaining portion 

of the applicable review period. 

IV. Statements of Administrator 

Findings Under TSCA Section 5(a)(3)(C) 

In this unit, EPA provides the 

following information (to the extent that 

such information is not claimed as 

Confidential Business Information 

(CBI)) on the PMNs, MCANs and 

SNUNs for which, during this period, 

EPA has made findings under TSCA 

section 5(a)(3)(C) that the new chemical 

substances or significant new uses are 

not likely to present an unreasonable 

risk of injury to health or the 

environment: 

• EPA case number assigned to the 

TSCA section 5(a) notice. 

• Chemical identity (generic name if 

the specific name is claimed as CBI). 

• Website link to EPA’s decision 

document describing the basis of the 

‘‘not likely to present an unreasonable 

risk’’ finding made by EPA under TSCA 

section 5(a)(3)(C). 

EPA case No. Chemical identity Website link 

J–21–0010 ................... Genetically modified microorganism for the production of a chemical 

substance (Generic Name).

https://www.epa.gov/reviewing-new-chemicals-under-toxic-substances-control-act-tsca/tsca-section-5a3c-determination-509. 

Authority: 15 U.S.C. 2601 et seq. Dated: July 7, 2021. 

Madison Le, 

Director, New Chemicals Division, Office of 

Pollution Prevention and Toxics. 

[FR Doc. 2021–15086 Filed 7–14–21; 8:45 am] 

BILLING CODE 6560–50–P 


khammond on DSKJM1Z7X2PROD with NOTICES